US Stock MarketDetailed Quotes

Lexaria Bioscience (LEXX)

Watchlist
  • 1.0300
  • +0.0450+4.57%
Close Apr 17 15:59 ET
  • 0.9800
  • -0.0500-4.85%
Post 18:20 ET
25.53MMarket Cap-2.19P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lexaria Bioscience (LEXX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Feb 28, 2026
(Q1)Nov 30, 2025
(FY)Aug 31, 2025
(Q4)Aug 31, 2025
(Q3)May 31, 2025
(Q2)Feb 28, 2025
(Q1)Nov 30, 2024
(FY)Aug 31, 2024
(Q4)Aug 31, 2024
(Q3)May 31, 2024
Total revenue
-88.51%20K
0
52.05%705.92K
107.14%174K
107.14%174K
20.00%174K
21.58%183.92K
105.24%464.28K
173.25%84K
8.10%84K
Operating revenue
-88.51%20K
--0
52.34%705.92K
107.14%174K
107.14%174K
20.00%174K
22.31%183.92K
142.65%463.38K
100.64%84K
8.10%84K
Cost of revenue
0
0
-43.59%2.72K
0
0
0
-43.59%2.72K
-84.69%4.82K
0
0
Gross profit
-88.51%20K
0
53.05%703.2K
107.14%174K
107.14%174K
20.00%174K
23.73%181.2K
135.97%459.46K
173.25%84K
29.31%84K
Operating expense
-49.68%1.47M
-45.21%1.57M
102.56%12.58M
25.16%2.86M
114.81%3.92M
259.78%2.93M
123.39%2.87M
-7.67%6.21M
99.77%2.29M
-25.91%1.83M
Selling and administrative expenses
-19.58%996.52K
-1.79%902.29K
12.80%4.35M
-25.71%980.48K
-3.74%1.21M
118.45%1.24M
29.19%918.69K
25.80%3.85M
104.80%1.32M
51.95%1.25M
-General and administrative expense
-19.58%996.52K
-1.79%902.29K
12.80%4.35M
-25.71%980.48K
-3.74%1.21M
118.45%1.24M
29.19%918.69K
25.80%3.85M
104.80%1.32M
51.95%1.25M
Research and development costs
-71.80%475.39K
-65.63%671.34K
249.02%8.24M
94.59%1.88M
374.18%2.72M
585.95%1.69M
239.99%1.95M
-35.62%2.36M
93.28%967.21K
-65.07%573.09K
Operating profit
47.22%-1.45M
41.52%-1.57M
-106.51%-11.88M
-22.04%-2.69M
-115.18%-3.75M
-311.83%-2.75M
-136.20%-2.69M
11.95%-5.75M
-97.74%-2.2M
27.40%-1.74M
Net non-operating interest income expense
1.77K
9.09%12
-78.92%3.02K
-59.73%2.82K
190
0
-99.85%11
-66.87%14.31K
-22.44%6.99K
0
Non-operating interest income
--1.77K
9.09%12
-78.92%3.02K
-59.73%2.82K
--190
--0
-99.85%11
-66.87%14.31K
-22.44%6.99K
--0
Other net income (expense)
-38.67%-22.09K
51.72%-33.71K
-220.49%-11.45K
2.46%-40.38K
122.88%34.04K
70.06%-15.93K
68.50%-69.84K
106.60%9.5K
-2,330.23%-41.39K
Gain on sale of security
----
-38.67%-22.09K
51.72%-33.71K
-220.49%-11.45K
2.46%-40.38K
122.88%34.04K
70.06%-15.93K
68.50%-69.84K
106.60%9.5K
-2,330.23%-41.39K
Income before tax
46.63%-1.45M
41.04%-1.6M
-105.06%-11.91M
-23.35%-2.7M
-112.44%-3.79M
-316.25%-2.72M
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
Income tax
2.6K
1.79K
0
0
Net income
46.53%-1.45M
40.98%-1.6M
-105.06%-11.91M
-23.35%-2.7M
-112.44%-3.79M
-316.25%-2.72M
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
Net income continuous Operations
46.53%-1.45M
40.98%-1.6M
-105.06%-11.91M
-23.35%-2.7M
-112.44%-3.79M
-316.25%-2.72M
-128.40%-2.71M
13.47%-5.81M
-75.06%-2.19M
25.14%-1.78M
Minority interest income
26.78%-2.75K
14.78%-2.5K
27.92%-9.59K
21.95%-1.39K
42.19%-1.51K
-17.72%-3.76K
48.75%-2.93K
72.06%-13.31K
81.63%-1.78K
78.29%-2.62K
Net income attributable to the parent company
46.56%-1.45M
41.01%-1.6M
-105.37%-11.9M
-23.39%-2.7M
-112.67%-3.79M
-317.71%-2.71M
-129.26%-2.7M
13.05%-5.8M
-76.29%-2.18M
24.87%-1.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
46.56%-1.45M
41.01%-1.6M
-105.37%-11.9M
-23.39%-2.7M
-112.67%-3.79M
-317.71%-2.71M
-129.26%-2.7M
13.05%-5.8M
-76.29%-2.18M
24.87%-1.78M
Basic earnings per share
60.00%-0.06
56.25%-0.07
-40.43%-0.66
13.33%-0.13
-61.54%-0.21
-150.00%-0.15
-23.08%-0.16
53.47%-0.47
-25.00%-0.15
64.86%-0.13
Diluted earnings per share
60.00%-0.06
56.25%-0.07
-40.43%-0.66
13.33%-0.13
-61.54%-0.21
-150.00%-0.15
-23.08%-0.16
53.47%-0.47
-25.00%-0.15
64.86%-0.13
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
(Q2)Feb 28, 2026(Q1)Nov 30, 2025(FY)Aug 31, 2025(Q4)Aug 31, 2025(Q3)May 31, 2025(Q2)Feb 28, 2025(Q1)Nov 30, 2024(FY)Aug 31, 2024(Q4)Aug 31, 2024(Q3)May 31, 2024
Total revenue -88.51%20K052.05%705.92K107.14%174K107.14%174K20.00%174K21.58%183.92K105.24%464.28K173.25%84K8.10%84K
Operating revenue -88.51%20K--052.34%705.92K107.14%174K107.14%174K20.00%174K22.31%183.92K142.65%463.38K100.64%84K8.10%84K
Cost of revenue 00-43.59%2.72K000-43.59%2.72K-84.69%4.82K00
Gross profit -88.51%20K053.05%703.2K107.14%174K107.14%174K20.00%174K23.73%181.2K135.97%459.46K173.25%84K29.31%84K
Operating expense -49.68%1.47M-45.21%1.57M102.56%12.58M25.16%2.86M114.81%3.92M259.78%2.93M123.39%2.87M-7.67%6.21M99.77%2.29M-25.91%1.83M
Selling and administrative expenses -19.58%996.52K-1.79%902.29K12.80%4.35M-25.71%980.48K-3.74%1.21M118.45%1.24M29.19%918.69K25.80%3.85M104.80%1.32M51.95%1.25M
-General and administrative expense -19.58%996.52K-1.79%902.29K12.80%4.35M-25.71%980.48K-3.74%1.21M118.45%1.24M29.19%918.69K25.80%3.85M104.80%1.32M51.95%1.25M
Research and development costs -71.80%475.39K-65.63%671.34K249.02%8.24M94.59%1.88M374.18%2.72M585.95%1.69M239.99%1.95M-35.62%2.36M93.28%967.21K-65.07%573.09K
Operating profit 47.22%-1.45M41.52%-1.57M-106.51%-11.88M-22.04%-2.69M-115.18%-3.75M-311.83%-2.75M-136.20%-2.69M11.95%-5.75M-97.74%-2.2M27.40%-1.74M
Net non-operating interest income expense 1.77K9.09%12-78.92%3.02K-59.73%2.82K1900-99.85%11-66.87%14.31K-22.44%6.99K0
Non-operating interest income --1.77K9.09%12-78.92%3.02K-59.73%2.82K--190--0-99.85%11-66.87%14.31K-22.44%6.99K--0
Other net income (expense) -38.67%-22.09K51.72%-33.71K-220.49%-11.45K2.46%-40.38K122.88%34.04K70.06%-15.93K68.50%-69.84K106.60%9.5K-2,330.23%-41.39K
Gain on sale of security -----38.67%-22.09K51.72%-33.71K-220.49%-11.45K2.46%-40.38K122.88%34.04K70.06%-15.93K68.50%-69.84K106.60%9.5K-2,330.23%-41.39K
Income before tax 46.63%-1.45M41.04%-1.6M-105.06%-11.91M-23.35%-2.7M-112.44%-3.79M-316.25%-2.72M-128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M
Income tax 2.6K1.79K00
Net income 46.53%-1.45M40.98%-1.6M-105.06%-11.91M-23.35%-2.7M-112.44%-3.79M-316.25%-2.72M-128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M
Net income continuous Operations 46.53%-1.45M40.98%-1.6M-105.06%-11.91M-23.35%-2.7M-112.44%-3.79M-316.25%-2.72M-128.40%-2.71M13.47%-5.81M-75.06%-2.19M25.14%-1.78M
Minority interest income 26.78%-2.75K14.78%-2.5K27.92%-9.59K21.95%-1.39K42.19%-1.51K-17.72%-3.76K48.75%-2.93K72.06%-13.31K81.63%-1.78K78.29%-2.62K
Net income attributable to the parent company 46.56%-1.45M41.01%-1.6M-105.37%-11.9M-23.39%-2.7M-112.67%-3.79M-317.71%-2.71M-129.26%-2.7M13.05%-5.8M-76.29%-2.18M24.87%-1.78M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 46.56%-1.45M41.01%-1.6M-105.37%-11.9M-23.39%-2.7M-112.67%-3.79M-317.71%-2.71M-129.26%-2.7M13.05%-5.8M-76.29%-2.18M24.87%-1.78M
Basic earnings per share 60.00%-0.0656.25%-0.07-40.43%-0.6613.33%-0.13-61.54%-0.21-150.00%-0.15-23.08%-0.1653.47%-0.47-25.00%-0.1564.86%-0.13
Diluted earnings per share 60.00%-0.0656.25%-0.07-40.43%-0.6613.33%-0.13-61.54%-0.21-150.00%-0.15-23.08%-0.1653.47%-0.47-25.00%-0.1564.86%-0.13
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Lebanon and Israel will implement a 10-day ceasefire! Iran's foreign minister, based on the Lebanon ceasefire agreement, announced the compl Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -